"UPDATE 2-CVC, Cinven eye $1 bln Turkish pharma deal-sources
By Seda Sezer and Ceyda Caglayan
ISTANBUL, April 8 (Reuters) - European buyout firms Cinven, CVC and Advent International are among potential buyers of a stake in Bilim Ilac in a sale that may value the Turkish drugmaker at about $1 billion, sources familiar with the deal said."
More:UPDATE 2-CVC, Cinven eye $1 bln Turkish pharma deal-sources | Reuters
